Drug name - Orgovyx

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US8058280 MYOVANT SCIENCES Substituted thieno[2,3-d]pyrimidin-2,4-dione compounds and uses thereof
Jan, 2024

(1 year, 3 months from now)

US7300935 MYOVANT SCIENCES Thienopyrimidine compounds and use thereof
Jan, 2024

(1 year, 3 months from now)

CN101153042A MYOVANT SCIENCES Thienopyrimidine Compounds And Use Thereof
Sep, 2011

(11 years ago)

CN100360538C MYOVANT SCIENCES Thienopyrimidine Compounds And Use Thereof
Jan, 2024

(1 year, 3 months from now)

CN1768065A MYOVANT SCIENCES Thienopyrimidine Compounds And Use Thereof
Jan, 2024

(1 year, 3 months from now)

IN235678B MYOVANT SCIENCES Thienopyrimidine Compounds And Use Thereof
Jan, 2024

(1 year, 3 months from now)

IN200501636P2 MYOVANT SCIENCES Thienopyrimidine Compounds And Use Thereof
Jan, 2024

(1 year, 3 months from now)

EP1591446A4 MYOVANT SCIENCES Thienopyrimidine Compounds And Use Thereof
Jan, 2024

(1 year, 3 months from now)

EP1591446A1 MYOVANT SCIENCES Thienopyrimidine Compounds And Use Thereof
Jan, 2024

(1 year, 3 months from now)

EP1591446B1 MYOVANT SCIENCES Thienopyrimidine Compounds And Use Thereof
Jan, 2024

(1 year, 3 months from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8735401 MYOVANT SCIENCES Thienopyrimidine compounds and use thereof Feb, 2024

(1 year, 4 months from now)

US10350170 MYOVANT SCIENCES Solid preparation Feb, 2036

(13 years from now)

US10449191 MYOVANT SCIENCES Treatment of prostate cancer Sep, 2037

(14 years from now)

US10786501 MYOVANT SCIENCES Treatment of prostate cancer Sep, 2037

(14 years from now)

Drugs and Companies using RELUGOLIX ingredient

Treatment: Treatment of adult patients with advanced prostate cancer that is sex-hormone-dependent; Treatment of adult patients with advanced prostate cancer

Dosage: TABLET;ORAL

More Information on Dosage
Strength Dosage Availability
120MG TABLET;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.